Latest Breaking News On - Dragen - Page 1 : vimarsana.com

Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Second Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode.

Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Earnings Call Transcript

Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Earnings Call Transcript August 10, 2023 Operator: Good day, ladies and gentlemen, and welcome to the Second Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be advised that today’s conference is […]

25 Greatest Impacts in 25 Years: Illumina and the Evolution of Genomics

NORTHAMPTON, MA / ACCESSWIRE / April 4, 2023 / IlluminaOriginally published on Illumina News CenterThis month, Illumina celebrates a quarter century of innovation, research, and passion. As a genomics

Illumina: Using Whole-Genome Sequencing To Study Early-Onset Parkinson's Disease

NORTHAMPTON, MA / ACCESSWIRE / February 15, 2023 / Illumina:Originally published on Illumina News CenterThe Norwegian term for virgin snow, "nysnø", seemed the appropriate inspiration to name Jennifer

Oil & gas players pursuing electrification in Norwegian Sea to curb emissions

OKEA and Equinor in collaboration with license partners have set the wheels into motion to electrify the Draugen field and Njord A platforms.

Financialnewsmedia.com: Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027

FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 6, 2022 /PRNewswire/ -- The global Cervical Cancer Treatment market has been expanding for several years and is projected to

Illumina, Inc.: Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health

New technology enables highest levels of accuracy at immense scale, with the power to sequence more than 20,000 genomes per year Our most sustainable high-throughput sequencer delivers

Illumina Supports Norway's Pioneering Precision Medicine Study

Illumina Supports Norway's Pioneering Precision Medicine Study

Illumina Supports Norway's Pioneering Precision Medicine Study - read this article along with other careers information, tips and advice on BioSpace

Illumina Supports Norway's Pioneering Precision Medicine Study

Illumina Supports Norway’s Pioneering Precision Medicine Study Study to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing SAN DIEGO, December 9, 2021 / PRNewswire / -- Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national preci...